Editorial to the IJMS Special Issue on "ncRNAS in Therapeutics"
- PMID: 37047420
- PMCID: PMC10095044
- DOI: 10.3390/ijms24076448
Editorial to the IJMS Special Issue on "ncRNAS in Therapeutics"
Abstract
For many years, the RNA world of eukaryotic cells remained stable and predictable, organized by a few families of functionally different molecules [...].
Conflict of interest statement
The authors declare no conflict of interest and the funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
References
-
- De Benedittis S., Fortunato F., Cava C., Gallivanone F., Iaccino E., Caligiuri M.E., Castiglioni I., Bertoli G., Manna I., Labate A., et al. Circulating microRNAs as Potential Novel Diagnostic Biomarkers to Predict Drug Resistance in Temporal Lobe Epilepsy: A Pilot Study. Int. J. Mol. Sci. 2021;22:702. doi: 10.3390/ijms22020702. - DOI - PMC - PubMed
-
- Di Fiore R., Suleiman S., Pentimalli F., O’Toole S.A., O’Leary J.J., Ward M.P., Conlon N.T., Sabol M., Ozretić P., Erson-Bensan A.E., et al. Could MicroRNAs Be Useful Tools to Improve the Diagnosis and Treatment of Rare Gynecological Cancers? A Brief Overview. Int. J. Mol. Sci. 2021;22:3822. doi: 10.3390/ijms22083822. - DOI - PMC - PubMed
-
- Kowara M., Borodzicz-Jazdzyk S., Rybak K., Cudnoch-Jedrzejewska A. Therapies Targeted at Non-Coding RNAs in Prevention and Limitation of Myocardial Infarction and Subsequent Cardiac Remodeling—Current Experience and Perspectives. Int. J. Mol. Sci. 2021;22:5718. doi: 10.3390/ijms22115718. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources